Switch to
More onapp

Wanbury Ltd

WANBURY
Health CarePharmaceuticals
SmallcapWith a market cap of ₹168 cr, stock is ranked 1,902
Moderate RiskStock is 2.54x as volatile as Nifty
50.450.15 (-0.30%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹168 cr, stock is ranked 1,902
Moderate RiskStock is 2.54x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
2.07
PB RatioPB Ratio
-7.21
Dividend YieldDiv. Yield
Sector PESector PE
35.90
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Wanbury Limited is a pharmaceutical company. The Company offers active pharmaceutical ingredient (API) in over 70 countries. The Company offers products in the categories, such as anti-diabetic, anti-depressant, anti-histaminic, anti-inflammatory, anti-depressant, anti-arthritis, anti-thrombotic, anti-epileptic and anti-hypertensive. The Company's API products include metformin, tramadol, sertraline, diphenhydramine citrate, mefenamic acid, paroxetine hemihydrate, promethazine, glucosamine, clopidogrel, levitiracetam and carvedilol phosphate monohydrate, among others. The Company operates through four divisions: Main division, which caters to general doctors; Osteolife, which offers solutions to orthopedic doctors; Surglife, which offers services to surgeons, and WOW, which caters to gynecologists. The Company's brands include Cpink, Rabiplus, Folinine, Adtrol Plus, CEMAX, AUGCEF, Pantastic, CHEER and Nurture, among others.

Financial TrendFinancial statements 

2019202020212022400.70451.23394.92589.07-24.8464.46-12.6081.50
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings